US Politics
Upholding Scientific Integrity: The Battle for Evidence-Based Mifepristone Regulation
A Johns Hopkins study analyzing FDA internal documents reveals the agency consistently based mifepristone regulatory decisions on scientific evidence from 2011-2023, with one notable political interference during the Trump administration. This chilling episode demonstrates how fragile evidence-based governance becomes when political agendas override medical expertise, threatening both reproductive freedom and institutional integrity.
